Effects of substance P on memory and mood in healthy male subjects

Human Psychopharmacology

Volumn 22, Issue 8, 2007, Pages 567-573

  Herpfer, Inga ^a   Katzev, Michael ^a   Feige, Bernd ^a   Fiebich, Bernd L ^a   Voderholzer, Ulrich ^a   Lieb, Klaus ^a,b  

^a UNIVERSITY OF FREIBURG   (Germany)

^b UNIVERSITY MEDICAL CENTER MAINZ   (Germany)

Author keywords

Anxiety; Cognition; Depression; Neurokinin 1 receptor; Neuropeptides; Substance P

Indexed keywords

PLACEBO; SODIUM CHLORIDE; SUBSTANCE P;

ADULT; ANXIETY; ARTICLE; ATTENTION; CLINICAL ARTICLE; COGNITIVE DEFECT; CONTROLLED STUDY; DEPRESSION; HUMAN; LEARNING; MALE; MEMORY DISORDER; MENTAL PERFORMANCE; MENTAL STRESS; MOOD DISORDER; PRIORITY JOURNAL; PSYCHOLOGICAL RATING SCALE; QUESTIONNAIRE; SELF CONCEPT; SHORT TERM MEMORY; SYMPTOM; TENSION;

ADULT; AFFECT; ANXIETY; ATTENTION; AUTONOMIC NERVOUS SYSTEM; CROSS-OVER STUDIES; DEPRESSION; DOUBLE-BLIND METHOD; HUMANS; INFUSIONS, INTRAVENOUS; MALE; MEMORY, SHORT-TERM; MENTAL RECALL; NEUROPSYCHOLOGICAL TESTS; PERSONALITY INVENTORY; SUBSTANCE P; VASODILATION;

EID: 37849013408     PISSN: 08856222     EISSN: 10991077     Source Type: Journal    
DOI: 10.1002/hup.876     Document Type: Article

References (42)

1. Barker R. 1991. Substance P and neurodegenerative disorders. A speculative review. Neuropeptides 20: 73-78.
2. Beck AT, Ward CH, Mendelson M, Mock J, Erbaugh J. 1961. An inventory for measuring depression. Arch Gen Psychiatry 4: 561-571.
3. Bondy B, Baghai TC, Minov C, et al. 2003. Substance P serum levels are increased in major depression: preliminary results. Biol Psychiatry 53: 538-542.
4. Clark JW, Senanayake PD, Solomon GD, Gallagher C. 1994. Substance P: correlation of CSF and plasma levels. Headache 34: 261-264.
5. Coiro V, Capretti L, Volpi R, et al. 1992. Stimulation of ACTH/ cortisol by intravenously infused substance P in normal men: inhibition by sodium valproate. Neuroendocrinology 56: 459-463.
6. Coiro V, Volpi R, Capretti L, et al. 1993. Intravenously infused substance P is unable to change basal and TRH-stimulated PRL secretion in normal men. Horm Res 39: 73-76.
7. de Quervain DJ, Roozendaal B, Nitsch RM, McGaugh JL, Hock C. 2000. Acute cortisone administration impairs retrieval of long-term declarative memory in humans. Nat Neurosci 3: 313-314.
8. Dillon DJ, Gorman JM, Liebowitz MR, Fyer AJ, Klein DF. 1987. Measurement of lactate-induced panic and anxiety. Psychiatry Res 20: 97-105.
9. First MB, Spitzer RL, Gibbon M, Williams JBW. 1996. User's Guide for the Structured Clinical Interview for DSM-IV Personality Disorders (SCID-II). American Psychiatric Press: Washington, D.C.
10. First MB, Spitzer RL, Gibbon M, Williams JBW, Benjamin LS. 1997. User's Guide for the Structured Clinical Interview for DSM-IV Axis I Disorders (SCID-I) - Clinical Version. American Psychiatric Press: Washington, D.C.
11. Freed AL, Audus KL, Lunte SM. 2002. Investigation of substance P transport across the blood-brain barrier. Peptides 23: 157-165.
12. Gouzoulis-Mayfrank E, Daumann J, Tuchtenhagen F, et al. 2000. Impaired cognitive performance in drug free users of recreational ecstasy (MDMA). J Neurol Neurosurg Psychiatry 68: 719-725.
13. Hasenohrl RU, Souza-Silva MA, Nikolaus S, et al. 2000. Substance P and its role in neural mechanisms governing learning, anxiety and functional recovery. Neuropeptides 34: 272-280.
14. Helmstaedter C, Durwen HF. 1990. The Verbal Learning and Retention Test. A useful and differentiated tool in evaluating verbal memory performance. Schweiz Arch Neurol Psychiatr 141: 21-30.
15. Herpfer I, Lieb K. 2003. Substance P and Substance P receptor antagonists in the pathogenesis and treatment of affective disorders. World J Biol Psychiatry 4: 56-63.
16. Herpfer I, Lieb K. 2005. Substance P receptor antagonists in psychiatry: rationale for development and therapeutic potential. CNS Drugs 19: 275-293.
17. Herpfer I, Hunt SP, Stanford SC. 2005. A comparison of neurokinin 1 receptor knock-out (NK1 -/-) and wildtype mice: exploratory behaviour and extracellular noradrenaline concentration in the cerebral cortex of anaesthetised subjects. Neuropharmacology 48: 706-719.
18. Holsboer F. 1995. Neuroendocrinology of mood disorders. Psychopharmacology 957-970.
19. Kramer MS, Cutler N, Feighner J, et al. 1998. Distinct mechanism for antidepressant activity by blockade of central substance P receptors. Science 281: 1640-1645.
20. Kramer MS, Winokur A, Kelsey J, et al. 2004. Demonstration of the efficacy and safety of a novel substance P (NK1) receptor antagonist in major depression. Neuropsychopharmacology 29: 385-392.
21. Lieb K, Ahlvers K, Dancker K, et al. 2002. Effects of the neuropeptide substance p on sleep, mood, and neuroendocrine measures in healthy young men. Neuropsychopharmacology 27: 1041-1049.
22. Lieb K, Walden J, Grunze H, Fiebich BL, Berger M, Normann C. 2004. Serum levels of substance P and response to antidepressant pharmacotherapy. Pharmacopsychiatry 37: 238-239.
23. Linkowski P, Mendlewicz J, Kerkhofs M, et al. 1987. 24-hour profiles of adrenocorticotropin, cortisol, and growth hormone in major depressive illness: effect of antidepressant treatment. J Clin Endocrinol Metab 65: 141-152.
24. Lupien SJ, Nair NP, Briere S, et al. 1999. Increased cortisol levels and impaired cognition in human aging: implication for depression and dementia in later life. Rev Neurosci 10: 117-139.
25. Montgomery SA, Keller M, Ball W, et al. 2004. Peptide approaches in the treatment of major depression- lack of efficacy of the substance P (neurokinin 1 receptor) antagonist aprepitant. Eur Neuropsychopharmacol 14 (suppl 3): S136.
26. Otsuka M, Yoshioka K. 1993. Neurotransmitter functions of mammalian tachykinins. Physiol Rev 73: 229-308.
27. Pioro EP, Mai JK, Cuello AC. 1990. Distribution of substance P and enkephalin immunoreactive neurons and fibers. In The Human Nervous System, Paxinos G (ed). Academic Press: San Diego, New York; 1051-1094.
28. Quartara L, Maggi CA. 1998. The tachykinin NK1 receptor. Part II: distribution and pathophysiological roles. Neuropeptides 32: 1-49.
29. Raber J. 1998. Detrimental effects of chronic hypothalamic-pituitary-adrenal axis activation. From obesity to memory deficits. Mol Neurobiol 18: 1-22.
30. Rimon R, Le Greves P, Nyberg F, Heikkila L, Salmela L, Terenius L. 1984. Elevation of substance P-like peptides in the CSF of psychiatric patients. Biol Psychiatry 19: 509-516.
31. Rupniak NM, Kramer MS. 1999. Discovery of the antidepressant and anti-emetic efficacy of substance P receptor (NK1) antagonists. Trends Pharmacol Sci 20: 485-490.
32. Schaffalitzky De Muckadell OB, Aggestrup S, Stentoft P. 1986. Flushing and plasma substance P concentration during infusion of synthetic substance P in normal man. Scand J Gastroenterol 21: 498-502.
33. Schedlowski M, Fluge T, Richter S, Tewes U, Schmidt RE, Wagner TO. 1995. Beta-endorphin, but not substance-P, is increased by acute stress in humans. Psychoneuroendocrinology 20: 103-110.
34. Sergeyev V, Hokfelt T, Hurd Y. 1999. Serotonin and substance P co-exist in dorsal raphe neurons of the human brain. Neuroreport 10: 3967-3970.
35. Spielberger C, Gorsuch R, Lushene R. 1970. The Stait-Trait Anxiety Inventory: Test Manual for Form x. Consulting Psychologists Press: Palo Alto, CA, USA.
36. Stout SC, Owens MJ, Nemeroff CB. 2001. Neurokinin(1) receptor antagonists as potential antidepressants. Annu Rev Pharmacol Toxicol 41: 877-906.
37. Voderholzer U, Laakmann G, Wittmann R, et al. 1993. Profiles of spontaneous 24-hour and stimulated growth hormone secretion in male patients with endogenous depression. Psychiatry Res 47: 215-227.
38. von Zerssen D. 1986. Clinical Self-rating scales (CSRS) of the Munich psychiatry information system (PSYCHIS München). In Assessment of Depression, Sasaki A, Ban E (eds.). Springer Verlag: Berlin.
39. Weiss DW, Hirt R, Tarcic N, et al. 1996. Studies in psychoneuroimmunology: psychological, immunological, and neuroendocrinological parameters in Israeli civilians during and after a period of Scud missile attacks. Behav Med 22: 5-14.
40. Wolf OT. 2003. HPA axis and memory. Best Pract Res Clin Endocrinol Metab 17: 287-299.
41. Wolf OT, Convit A, McHugh PF, et al. 2001. Cortisol differentially affects memory in young and elderly men. Behav Neurosci 115: 1002-1011.
42. Zimmermann B, Fimm B. 1995. Test for Attentional Performance (TAP). PsyTest: Herzogenrath.